墨西哥乳腺癌幸存者的诊断和治疗知识:一个横截面研究
Citlali Frayde-Aguilar1, Maria Andrea Mac Donald-Jaramillo1, Raúl Emiliano Esparza-Orozco1
1Hemato-Oncology Department, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
Patient education and counseling
|November 9, 2025
概括
乳腺癌幸存者比诊断更了解治疗方法. 报告说,人们对瘤学家沟通的满意度很高,但知识缺口仍然存在,特别是在诊断细节方面.
科学领域:
- 在瘤学瘤学.
- 患者护理 患者护理
- 卫生沟通健康沟通
背景情况:
- 越来越多的乳腺癌幸存者需要改善长期后续护理.
- 需要增强患者知识和参与幸存者的参与.
研究的目的:
- 评估乳腺癌幸存者的诊断和治疗知识.
- 评估对所收到信息的满意度.
- 感知瘤学家的沟通技巧.
主要方法:
- 对181名乳腺癌I-III期幸存者的调查,使用36个问题.
- 通过将调查答案与医疗记录进行比较来评估知识.
- 关于统计学关联的奇平方和费舍尔测试.
主要成果:
- 幸存者对治疗 (82.3%) 和诊断 (10.5%) 的知识更高.
- 高等教育和5年内诊断与更好的诊断知识相关.
- 95%的幸存者认为瘤学家充分传达了诊断和治疗信息.
结论:
- 乳腺癌幸存者更了解治疗方法,而不是诊断具体情况.
- 对瘤学家的沟通和信息传递的高度满意.
- 识别的知识差距和影响回忆的因素强调了有效的瘤学家沟通的重要性.
更多相关视频
10:55Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System
Published on: January 8, 2018
11.5K
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
7.0K
相关概念视频
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
